Euromonitor Profiles, July 2015
This Company Profile from Euromonitor provides key details and analysis of JCB Co Ltd, the owner of brands such as Tylenol, Zyrtec and Nicorette. Included is a strategic evaluation with key facts about the US company, competitive positioning against comparative brands, and assessment of its position in the pharmaceutical market.
Nielsen, April 2015
This article explains how research company Nielsen helped healthcare company Care Innovations improve its online platform.
Stephen Whiteside, Event Reports, IEG Sponsorship, May 2015
This event report outlines how the Mayo Clinic tied a sponsorship program with the Minnesota Timberwolves and Lynx basketball teams to a new strategic vision.
Deb Furey and Kent Groves, Warc Exclusive, April 2015
This articles explains why pharmaceutical brands need to take a more personalised approach to marketing to healthcare providers in the US.
Crawford Hollingworth, Warc Exclusive, The Behavioural Architects, March 2015
This article examines how behavioural economics can help people adhere to medical advice more consistently, improving their own long-term health and reduce costs to healthcare providers.
Theun de Bruijn, Event Reports, South by Southwest, March 2015
This event report covers three of the main themes running through South By Southwest 2015 in Austin, Texas.
ARF Ogilvy Awards, Gold, Health & personal care and Gold, Pharmaceutical, 2015
This case study explains how Emergen-C, a dietary supplement brand owned by pharmaceuticals company Pfizer, took a new approach to the category to increase sales and market share.
ARF Ogilvy Awards, Silver, Pharmaceutical, 2015
This case study describes the launch of XELJANZ in the US, a new drug by pharmaceutical company Pfizer, with a campaign that showed the brand truly understood the lives and difficulties of sufferers of rheumatoid arthritis (RA).
Geoffrey Precourt, Event Reports, ANA Brand Masters, February 2015
This event report shows how Zyrtec, the anti-allergy medication, has successfully closed the gap on Claritin, the leader in the sector.